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Lilly Corporate Center 1523 preventing the deacylation step of the reaction from
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of these inhibitors may thus be distinguished from mech-
anism-based “suicide” substrates, such as clavulanate,
which rely on secondary chemical reactions within theSummary
enzyme, and also from classical noncovalent substrate-
based inhibitors, such as the dihydrofolate reductase-lactamases confer resistance to -lactam antibiot-
ics such as penicillins and cephalosporins. However, inhibitor methotrexate or the trypsin inhibitor benzami-
dine, which rely on steric and electrostatic complemen--lactams that form an acyl-intermediate with the en-
zyme but subsequently are hindered from forming a tarity to the active site.
An example of a chemical group that appears to forcecatalytically competent conformation seem to be in-
hibitors of -lactamases. This inhibition may be im- a catalytically incompetent conformation in the binding
site of AmpC -lactamase is the 2-amino-4-thiazolyl me-parted by specific groups on the ubiquitous R1 side
chain of -lactams, such as the 2-amino-4-thiazolyl thoxyimino (ATMO) group common among third-genera-
tion cephalosporins, such as cefotaxime and ceftazi-methoxyimino (ATMO) group common among third-
generation cephalosporins. Using steric hindrance of dime (Figure 1). The structure of the acyl-adduct of
ceftazidime with AmpC suggested that this ATMOdeacylation as a design guide, penicillin and carba-
cephem substrates were converted into effective group, which occurs at the distal end of the molecule,
forces the dihydrothiazine ring of the cephalosporin into-lactamase inhibitors and antiresistance antibiotics.
To investigate the structural bases of inhibition, the a configuration where it destabilizes the formation of the
deacylation transition state relative to good substrates,crystal structures of the acyl-adducts of the penicillin
substrate amoxicillin and the new analogous inhibitor thereby making it an inhibitor or very poor substrate of
AmpC [10]. In counterpoint to these structural studies,ATMO-penicillin were determined. ATMO-penicillin
binds in a catalytically incompetent conformation re- a series of elegant enzymological studies of third-gener-
ation cephalosporins has suggested that part of theirsembling that adopted by third-generation cephalo-
sporins, demonstrating the transferability of such ste- ability to inhibit class C -lactamases is conferred by
an internal electronic rearrangement that displaces therically hindered groups in inhibitor design.
R2 side chain peculiar to cephalosporins. This R2 group
sits at the C3 position of the dihydrothiazine ring (FigureIntroduction
1) of cephalosporins and has itself become the subject
of much synthetic effort in novel -lactam design. WhenThe impact of bacterial resistance on antimicrobial che-
motherapy is a pressing public health problem [1–3]. the lactam ring is opened as a result of attack by the
serine nucleophile (Ser64 in AmpC), the lone pair elec-Among the antibiotic classes most affected are the
-lactams, such as the penicillins and cephalosporins, trons on the formerly lactam nitrogen are free to re-
arrange, leading to the departure of the displaceablewhich are also among the most prescribed. The most
R2 side chain (Figure 2). The resulting ring structure iswidespread resistance mechanism to these antibiotics
thought to be more stable to hydrolytic attack [11–14].is the expression of -lactamases [4], which hydrolyze
In cephalosporins that are rapidly hydrolyzed, this re-these drugs, thereby inactivating them. All -lactams
arrangement happens slower than hydrolysis of the acyl-share the same core four-membered lactam ring from
enzyme species and consequent product formation andwhich they take their name. It is this core structure that is
thus does not affect how well the -lactam might inhibithydrolyzed by -lactamases. Intriguingly, substitutions
the enzyme. For molecules that are intrinsically slow todistant from the lactam ring can convert a -lactamase
deacylate, for instance because of steric interactionssubstrate into a -lactamase inhibitor. For instance,
in their R1 side chains, this rearrangement will happenamoxicillin and cephalothin are excellent substrates for
before deacylation, thereby further stabilizing the acylclass C -lactamases such as AmpC, whereas cloxacil-
adduct against deacylation. In such cases, the -lactamlin and ceftazidime (Figure 1) are either inhibitors or very
will be a slow substrate, to the point where it may bepoor substrates for these enzymes. Structural studies
considered an inhibitor of the -lactamase.
If steric hindrance plays a dominant role in the inhibi-3 Correspondence: blaszczak_larry_c@lilly.com (L.C.B.), b-shoichet@
northwestern.edu (B.K.S.) tion of class C -lactamases by third-generation cepha-
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Table 1. Kinetic Data for Hydrolysis of Analogous -Lactams by
AmpC -Lactamase
ATMO
Compound R1 group kcat (s1)a KM (M)a
Cephalothin  263 31
Cefotaxime  0.0448 0.80b
Penicillin G  133 5.0
ATMO-penicillin  0.0045 0.90b
Loracarbef  118 24
ATMO-carbacephem  0.0323 0.080b
a Kinetic constants are accurate to within 20%.
b IC50 reported instead of KM [14].
-lactams, which we will refer to as ATMO-penicillin and
ATMO-carbacephem (Figure 1), were indeed effective
inhibitors, with IC50 values of 900 nM and 80 nM, respec-
tively. To investigate the structural basis for this inhibi-
tion, the structure of the ATMO-penicillin/AmpC com-
plex was determined by X-ray crystallography to 1.72 A˚
resolution and compared to the structure of AmpC in
complex with a substrate, amoxicillin, which was deter-
mined to 1.87 A˚ resolution. To investigate the biological
relevance of these inhibitors, the efficacy of ATMO-car-
bacephem was investigated in bacterial cell culture.
These studies suggest a structural basis for the actions
of these and potentially other sterically hindered inhibi-
tors of class C -lactamases, one that may have use in
the design of new agents to overcome bacterial resis-
tance.Figure 1. Class C-Lactamase Substrates and Inhibitors Discussed
in This Paper
Results
Enzymologylosporins, then introduction of the ATMO group should
convert other classes of -lactams from substrates to The AmpC-catalyzed hydrolysis of the -lactams cefo-
taxime, ATMO-penicillin, and ATMO-carbacephem (Fig-inhibitors. Conversely, it may be that such side chains
will only confer inhibition to -lactams that also have a ure 1) were monitored by UV-Vis spectroscopy (Table
1). Consistent with the notion that steric hindrance candisplaceable R2 side chain, which are generally re-
stricted to the cephalosporins and oxacephems. Here, confer inhibition across -lactam families, all of these
ATMO-bearing -lactams were good inhibitors forwe investigate this question by introducing the ATMO
group onto penicillin and carbacephem scaffolds, nei- AmpC. Indeed, the kcat of ATMO-penicillin was so low
that we were only able to assign an upper bound ofther of which has a displaceable R2 side chain. The new
Figure 2. Two Possible Routes of Cephalo-
sporin Hydrolysis by Class C -Lactamases
The center scheme shows the overall reaction
pathway, involving nucleophilic attack by a
catalytic serine residue and eventual deacyl-
ation leading to hydrolyzed antibiotic, de-
parted R2 leaving group, and free enzyme.
The scheme on the left depicts the case
where deacylation occurs rapidly, freeing the
hydrolyzed antibiotic, which subsequently
undergoes the electronic rearrangement that
leads to the departure of the R2 group. The
scheme on the right depicts the case where
deacylation occurs more slowly, and so the
electronic rearrangement and departure of
the R2 group occurs while the -lactam is still
covalently bound to the enzyme.
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Table 2. Data Collection and Refinement Statistics
AmpC  Amoxicillin AmpC  ATMO-Penicillin
Space group C2 C2
Unit cell dimensions (A˚, deg) a  118.33, b  76.85 a  118.66, b  76.73
c  97.99,   116.51 c  98.17,   116.19
Number of complexes per asymmetric unit 2 2
Resolution (A˚) 1.87 1.72
Number of observed reflections 225,850 270,758
Number of unique reflections 63,012 81,383
Completeness (%) 97.0 (97.0)a 97.0 (95.3)a
Rmerge (%) 5.6 (37.3)a 3.5 (24.3)a
I/I	 30.70 (3.92)a 31.49 (4.36)a
Number of working reflections 56,774 74,290
Resolution range for refinement (A˚) 20.0–1.87 (1.91–1.87)a 20.0–1.72 (1.76–1.72)a
Number of protein residues 715 715
Number of water molecules 353 598
Rmsd for bond lengths (A˚) 0.0057 0.0126
Rmsd for bond angles (deg) 1.34 1.71
Rcryst (%) 19.9 17.8
Rfree (%) 22.3b 19.9c
Average B-factor (A˚2)
Protein 29.16 23.62
Ligandd 35.70 29.46
Solvent 29.60 29.94
a Values in parentheses are for the highest-resolution shell used in refinement.
b Rfree was calculated with 2048 reflections set aside randomly.
c Rfree was calculated with 2324 reflections set aside randomly.
d Catalytically competent conformation only.
0.0045 s1 for this value. As is common with -lactam cally incompetent conformation; the rest of the ligand
position remains mostly unperturbed in the active site.inhibitors of -lactamases, the KM was too low to be
determined for these ATMO-bearing inhibitors. Follow- The transient existence of multiple conformations of the
acyl-enzyme species has been suggested previously bying Pratt and colleagues [14], we use the inhibition IC50
values for these compounds as proxies for KM rates both Fourier transform infrared spectroscopic (FTIR) [17,
18] and crystallographic [19] studies. Further discussionwhen calculating turnover rates.
To isolate the role of bulky R1 groups from possible will focus on the catalytically competent conformation
of the ligand.influences due to R2 side chain displacement on the
inhibitory effect of these compounds, the turnover rates Key hydrogen-bonding interactions in the active site
(Figure 3C) closely resemble those typically seen in co-of -lactam substrates from the same -lactam families
were determined. Cephalothin (for comparison to cefo- valent complexes of -lactams with AmpC. These in-
clude the key interactions between the amide group oftaxime), penicillin G (for comparison to ATMO-penicillin),
and loracarbef (for comparison to ATMO-carbacephem) the R1 side chain (Figure 1) and the conserved residues
Gln120, Asn152, and Ala318 [5–7, 19, 20]. The putativewere good substrates for AmpC, with kcat values of 263
s1, 133 s1, and 118 s1, respectively, about 104- to 105- deacylating water, Wat402, is also clearly observed and
is stabilized by its interaction with Thr316. The positionfold faster than their ATMO-bearing analogs (Table 1).
of Wat403, also important in the catalytic mechanism
of AmpC [19], is also nearly identical to that seen inCrystal Structure of AmpC in Complex
with Amoxicillin other substrate complexes [6, 19].
The crystal structure of amoxicillin (Figure 1) covalently
bound to AmpC was determined to a resolution of 1.87 A˚ Crystal Structure of AmpC in Complex
with ATMO-Penicillin(Table 2). 91.3% of the amino acid residues were in the
“most favored” regions of the Ramachandran plot, and The crystal structure of ATMO-penicillin (Figure 1) cova-
lently bound to AmpC was determined to a resolutionthe remaining 8.7% were in “additionally allowed” re-
gions. The final Rcryst and Rfree values of the refined model of 1.72 A˚ (Table 2). 92.8% of the amino acid residues
were in the “most favored” regions of the Ramachandranwere 19.9% and 22.3%, respectively.
Due to the high resolution of this structure, we were plot, and 7.2% were in “additionally allowed” regions.
The final Rcryst and Rfree values of the refined model wereable to distinguish two distinct conformations of amoxi-
cillin in its covalent complex. The predominant confor- 17.8% and 19.9%, respectively. As with the amoxicillin
complex, two distinct conformations of the acyl-enzymemation (Figure 3A), modeled at 75% occupancy, shows
the -lactam carbonyl oxygen oriented in a catalytically species were captured in the crystal structure: a more
predominant conformation with the -lactam carbonylcompetent conformation in the “oxyanion” [15] or “elec-
trophilic” [16] hole formed by the backbone amide oxygen in the oxyanion/electrophilic hole (Figure 3B)
and a lower occupancy (25%) conformation with thegroups of Ser64 and Ala318. The other conformation
shows this oxygen swung “out” of the hole in a catalyti- -lactam carbonyl oxygen swung out of the oxyanion/
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Figure 3. The Active Site of AmpC Covalently Bound to a Substrate and an Inhibitor -Lactam
2|FO|-|FC| electron density of the refined models of AmpC in complex with the (A) substrate amoxicillin and the (B) inhibitor ATMO-penicillin,
contoured at 1. Carbon atoms are colored gray, oxygen atoms red, nitrogens blue, and sulfurs yellow. The putative deacylating water,
Wat402, is shown as a red sphere. Key hydrogen bond interactions in the active site of AmpC covalently bound to (C) amoxicillin and (D)
ATMO-penicillin. Amoxicillin carbon atoms are colored indigo, and ATMO-penicillin carbons are sea green. Wat402 is the deacylating water
and is colored the same as ligand carbons.
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Table 3. Minimum Inhibitory Concentrations (g/ml) of Representative -Lactams against Several Bacteria
Bacteria Cephalothin Cefotaxime Loracarbef ATMO-Carbacephem
E. coli not expressing AmpC -lactamase 8 0.00781 4 0.25
E. coli expressing AmpC -lactamase 64 0.0313 8 1
E. cloacae expressing -lactamase 	2048 64 256 64
S. aureus expressing -lactamase 0.25 1 2 2
electrophilic hole. The position of key active site resi- hydrolytic attack in the case of -lactams bound to
-lactamases. If conformational distortion is indeed adues has not changed significantly from the position
adopted in the AmpC/amoxicillin complex, with an rmsd useful design principal, it should be possible to transfer
groups that confer it to other families of -lactams, con-of 0.18 A˚ for those residues shown in Figures 3C and 3D.
Key hydrogen-bonding interactions in the active site verting substrates into inhibitors. The ability to convert
two different classes of substrates for AmpC, a penicillin(Figure 3D) in this complex resemble other covalent
complexes of -lactams with AmpC. A key difference and a carbacephem, into submicromolar inhibitors by
the addition of an appropriate R1 group from a thirdbetween ATMO-penicillin and substrate complexes,
such as those with loracarbef [6], cephalothin [19], and class, the cephalosporins, is thus consistent with this
idea and suggests that the bulky ATMO group of theamoxicillin (above), is that the entire inhibitor is rotated
such that the C3 carboxylate and the thiazolidine ring third-generation cephalosporins is the primary determi-
nant of inhibition for all three classes of inhibitors. Thisnitrogen occupy positions different from those adopted
by substrate -lactams. This conformation resembles may be understood in detail by considering the kinetic
and structural attributes of these inhibitors.that adopted by ceftazidime in its complex with AmpC
and, like ceftazidime, seems to owe to interactions be-
tween the ATMO group and highly conserved residues Enzymology
at the distal end of the AmpC site, such as Val211 and The hydrolytic rate constants, kcat, for cefotaxime,
Tyr221 [10]. The putative deacylating water is still ob- ATMO-penicillin, and ATMO-carbacephem are low
served in this complex, stabilized by both Thr316 and enough, 104- to 105-fold reduced compared to their anal-
a -lactam carboxylate oxygen. ogous substrates, that they may be usefully considered
to be inhibitors of AmpC (Table 1). When tested in the
Microbiology presence of a good substrate such as cephalothin or
Serial dilution assays in ligand culture were performed nitrocefin, these ATMO-containing -lactams have IC50
to examine the efficacy of sterically hindered -lactams values ranging from 900 nM for ATMO-penicillin to 80
against clinically relevant pathogens (Table 3). Against nM for ATMO-carbacephem (Table 1). In a series of
-lactamase-expressing Escherichia coli, cefotaxime elegant enzymological studies [11–14, 21], Pratt and col-
had an MIC of 0.031 g/ml and ATMO-carbacephem leagues have shown that the inhibition conferred by
had an MIC of 1 g/ml, both much improved compared the ATMO group in third-generation cephalosporins is
to the analogous -lactams cephalothin and loracarbef, coupled to the ability of the R2 side chain of these
which had MIC values of 64 and 8 g/ml, respectively. -lactams to depart when in the acyl-adduct complex,
When tested against a clinical isolate of Enterobacter rendering the resulting adduct less susceptible to hy-
cloacae that hyperproduces-lactamase, ATMO-carba- drolytic attack (Figure 2). Others have posited that it is
cephem and cefotaxime were again much more effective not the displaceability of this R2 side chain but rather
than their analogous parent compounds. Against a clini- the electron-withdrawing inductive effect that this group
cal isolate of Staphylococcus aureus that expresses a has on the -lactam core [22, 23] that is more important.
class A -lactamase, ATMO-carbacephem was just as For ATMO-penicillin and ATMO-carbacephem, which do
effective (2 g/ml) as loracarbef, whereas cefotaxime not have a displaceable R2 group, neither of these expla-
was slightly worse (1 g/ml versus 0.25 g/ml) than nations is true; the entire inhibitory effect may be attrib-
cephalothin, as might be expected of a third-generation uted to the addition of the ATMO side chain. This may be
cephalosporin. The ATMO-bearing -lactamase inhibi- understood quantitatively by comparing the deacylation
tors also showed good efficacy as antibiotics them- rate constants, kcat, for the ATMO-bearing inhibitors to
selves against -lactamase-negative E. coli, with MIC their analogous substrates that lack this group. The ra-
values of 0.008 g/ml and 0.25 g/ml for cefotaxime tios of the turnover rates (Table 1) for each pair of
and ATMO-carbacephem, respectively. -lactams (ATMO-bearing inhibitor divided by non-
ATMO-bearing substrate) can be compared:
Discussion
(I)
cefotaxime kcat
cephalothin kcat
(II)
ATMO-penicillin kcat
penicillin G kcat
(III)
ATMO-carbacephem kcat
loracarbef kcat
Sterically hindered inhibitors are recognized well
enough by an enzyme to form a covalent adduct, but Were the ratio (I) in the cephalosporin pair (with a readily
displaceable acetate R2 group) lower than that for theonce in that adduct are distorted away from a catalyti-
cally competent conformation because such a confor- penicillin (II) or carbacephem (III) pairs (which have no
displaceable R2 group), then the rapid departure of themation would require steric clashes between the ligand
and the enzyme. It is therefore difficult for the intermedi- cephalosporin R2 group would be key to trapping the
complex in its acyl-enzyme state (since cefotaxime andate to move on to the next stage of the reaction—
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cephalothin have identical R2 groups), and the inhibitory cephalosporin substrates, and that the hydrolytic mech-
anism seems to be shared among these different classeseffect of the ATMO group would not be fully transferable
to -lactams that lack an R2 group. However, this is not of -lactams.
observed: the kcat ratio is actually larger for the cephalo-
sporin pair (1.71 
 104) than for the penicillin pair
Crystal Structure of AmpC in Complex(3.38 
 105) and very similar to the carbacephem pair
with ATMO-Penicillin(2.73 
 104), indicating that the ATMO-containing ana-
The acyl-adduct structure of AmpC covalently bound tologs for these -lactams are just as or more stable to
ATMO-penicillin closely resembles that when bound tohydrolysis compared to their analogous substrate than
the third-generation cephalosporin ceftazidime (Figureis the cephalosporin (Table 1). Qualitatively, the same
1). Like ceftazidime, the bulky ATMO group on the peni-pattern may be seen if the IC50 values for cefotaxime,
cillin derivative appears to force the thiazolidine ring (theATMO-penicillin, and ATMO-carbacephem are com-
analog of the dihydrothiazine ring on the cephalosporin)pared – the value for ATMO-carbacephem is 11-fold
into a conformation where it would block the formationlower than that of cefotaxime and the value for ATMO-
of the high-energy deacylation intermediate. Althoughpenicillin is comparable to cefotaxime (we note that IC50
the ATMO R1 group is somewhat smaller than that ofvalues convolute acylation and deacylation rate con-
ceftazidime, a comparison of the binding modes ofstants, and so must be interpreted with care). These
ATMO-penicillin and ceftazidime indicates that the R1results demonstrate the transferability of bulky R1
groups bind very similarly, with nearly identical positionsgroups that have thus far been used only in the context
for the amide groups, aminothiazole rings, and methoximeof cephalosporins and monobactams (in the case of
substituents. The additional bulk of the 1,1-dimethyl-1-aztreonam). The synthesis of new -lactams that incor-
carboxylate group of ceftazidime appears to only furtherporate these groups thus need not be limited to cephalo-
displace the six-membered cephalosporin ring relativesporins, but in fact should be general to any compound
to the five-membered penicillin ring of ATMO-penicillin.with the -lactam core, such as the penicillins and car-
The fundamental mechanism of inhibition observed isbacephems demonstrated here.
the same as was observed with cloxacillin [6], moxalac-
tam [6, 9], and ceftazidime [10], namely the destabiliza-
tion of the deacylation transition state. In contrast toCrystal Structure of AmpC in Complex
with Amoxicillin the 3.0 A˚ distance between the -lactam ring nitrogen
of amoxicillin and the position of the deacylating waterTo understand the structural bases of how the ATMO
group confers inhibition to the penicillins, it was first in the high-energy intermediate state, the analogous
distance in the ATMO-penicillin complex would be anecessary to determine the structure of a penicillin sub-
strate of AmpC. This complex between wild-type AmpC mere 1.7 A˚ (Figure 4C). These atoms would be so close
in space as to be in van der Waals violation; thus theand amoxicillin is the first structure of a penicillin sub-
strate in complex with a class C -lactamase. Penicillin formation of the deacylation transition state would be
destabilized by the position of the ring nitrogen relativesubstrates bind in the active site of AmpC (Figure 4A) in
a nearly identical manner as the carbacephem substrate to the degree of stabilization afforded to the transition
state by the substrates.loracarbef [6] and the cephalosporin substrate cephalo-
thin [19]. In this, the class C -lactamases appear differ- Of interest to the specialist will be the two conformers
that we observe in both the amoxicillin and ATMO-peni-ent from the class A -lactamases, where cephalo-
sporins and penicillins are seen to adopt different cillin complexes with AmpC. FTIR spectroscopic studies
[17, 18] suggest that, in their acyl-adducts with -lacta-conformations in the active site [24]. The key interac-
tions between the R1 amide group and conserved active mases, the carbonyl group that forms the ester with the
catalytic serine (Ser64 in AmpC) can adopt more thansite residues Gln120, Asn152, and Ala318 are retained,
as is the positions of the -lactam carbonyl oxygen. The one conformation. Until recently, there had been no
crystallographic evidence for such libration within thefive-membered penicillin ring overlays closely with the
six-membered loracarbef and cephalothin rings, as do acyl adduct. Recent X-ray structures involving both
class A [25] and class C [19] -lactamases have sug-the ubiquitous carboxylate substituents on each of
these rings. The putative deacylating water, Wat402, gested that such alternate conformations can indeed be
observed crystallographically. The resolution of the struc-occupies a nearly identical location as that seen in the
loracarbef and cephalothin complexes, implying a cata- tures reported here is sufficient to discern both the ca-
nonical conformation, with the carbonyl oxygen in thelytic mechanism identical to that seen with the cephalo-
sporins [19]. Overlaying the structure of the amoxicillin/ “oxyanion” [15] or “electrophilic” [16] hole (modeled at
75% occupancy in each structure), and the conforma-AmpC complex with that of a deacylation transition-
state analog bearing the ceftazidime R1 side chain, com- tion with the carbonyl oxygen flipped out of the hole
(modeled at 25% occupancy). Given the FTIR data [17,pound 1 (Figure 1), in complex with AmpC [10] shows
that the -lactam ring nitrogen is positioned to stabilize 18], these alternate conformations may be kinetically
relevant. As a crystallographic matter, they may partlythe deacylation transition state complex, being 3.0 A˚
from the expected position of the deacylating water in explain why it has been possible to capture the acyl-
adduct of the substrate amoxicillin in the wild-type crys-the high-energy intermediate (Figure 4B). In short, we
see that the catalytically competent conformation of tal, as the activity of the enzyme clearly is slowed in the
crystal environment.amoxicillin closely resembles that of carbacephem and
Sterically Hindered Inhibitors of -Lactamases
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Figure 4. Steric Hindrance and Inhibition
AmpC in complex (A) with the substrates
amoxicillin (in indigo), loracarbef [6] (in gold),
and cephalothin [19] (in cyan). AmpC com-
plexes with (B) amoxicillin (in indigo) and (C)
ATMO-penicillin (in sea green) overlaid with
the deacylation transition state analog 1 [10]
(in light blue). (The dimethyl-carboxylate group
of the transition state analog has been omit-
ted for clarity.) The distance between the ring
nitrogen and the presumed position of the
hydrolytic water in the deacylation high-
energy intermediate is indicated.
Implications for Inhibitor Design compounds with bulky 6(7) groups [6, 9, 25]. Of course,
steric bulk alone is an overly simplistic description forPerhaps the result with the most therapeutic implica-
tions to emerge from the high-resolution structure of these effects. A relatively small group in the right posi-
tion, such as the 7-methoxy in moxalactam, can con-ATMO-penicillin in complex with AmpC is insight into
the transferability of bulky R1 groups responsible for vert a substrate into an inhibitor, whereas a bulky group
in the wrong position can leave the -lactam a substrate.inhibition. ATMO and other bulky groups have become
mainstays in the design of synthetic third- and fourth- For the steric hindrance approach to be effective, the
groups must be introduced in such a way as to forcegeneration cephalosporins, with little obvious attempt
to apply this chemical design to other families of an unfavorable interaction with the enzyme in the acyl
adduct. Given the structure of a substrate-enzyme com--lactams. Examination of the binding modes of several
ligands with very similar bulky R1 substituents shows plex, the design of a distorting bulky group is typically
straightforward, indeed much more so than the designnearly identical modes of binding—and consequently
inhibition—among various -lactam families: monobac- of complementary interactions, which are the focus of
classical structure-based inhibitor design. By addingtams [5], cephalosporins [10], and now penicillins. The
size of the ligand’s second ring, whether zero-mem- bulky substituents to a conserved core essential for
recognition by the enzyme (the -lactam ring), goodbered in the case of monobactams, five-membered in
the case of penicillins, or six-membered in the case of substrates can be turned into potent inhibitors.
Because the pharmacological and synthetic proper-the cephalosporins (and, presumably, carbacephems as
well), does not seem to affect the key mechanism of ties of the various -lactam families are well understood,
these insights may be useful in designing new leads forinhibition, namely destabilization of the deacylation tran-
sition state relative to substrate deacylation. drug discovery against -lactamases. Indeed, in cell
culture studies ATMO-carbacephem was much moreThe use of destabilizing groups as components of
-lactamase inhibitors is a recurring synthetic theme, effective against gram-negative bacteria that express
class C -lactamases (Table 3) than was loracarbef orand similar inhibition has been demonstrated before in
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2-Chloro-4,6-dimethoxy-1,3,5-triazine (966 mg, 5.5 mMol) andcephalothin and was about as effective as ceftazidime.
N-methylmorpholine (0.583 ml, 5.3 mMol) were added. The mixtureAlthough ATMO-carbacephem was no better than lora-
was stirred at room temperature for 30 min, at which time the systemcarbef against a Staphylococcus aureus clinical isolate
was a homogeneous solution of active ester. In a separate flask,
that expresses a class A -lactamase and worse than the tosylate salt of allyl penicillanate [26] (2.31 g, 5.4 mMol) was
the traditional amoxicillin/clavulanate, its MIC values are slurried in acetonitrile (11 ml). N-methylmorpholine (1.21 ml, 11
mMol) was added and the mixture was stirred until homogeneous.low enough to be interesting as a lead compound.
The penicillin solution was then added to the ATMO-active ester
solution via syringe over2 min, and the resulting acylation mixture
Significance was stirred at room temperature for 12 hr. The reaction mixture was
diluted with ethyl acetate and partitioned with 0.2 M phosphate
buffer at pH 4. The organic phase was washed with additional 0.2-lactamases are important therapeutic targets be-
M phosphate buffer at pH 4 (3
) and brine (1
), dried (anhydrouscause of their prominent role in resistance to-lactam
magnesium sulfate), and finally concentrated in vacuo to an oil.antibiotics, such as penicillins and cephalosporins.
The crude ATMO-penicillin allyl ester (2.23 g) was adsorbed onThe characteristics separating -lactam substrates
silica gel-60 (10 g) and chromatographed over silica gel-60 (10 g)
from -lactam inhibitors of these enzymes have been using a gradient elution of chloroform to 10% methanol in chloro-
the subject of much research. Here we find that the form. Appropriate fractions were combined and concentrated in
vacuo to yield an oil (1.83 g, 83%) with spectral characteristics (ES/substitution of an appropriate bulky side chain in place
MS, 1H NMR) consistent with ATMO-penicillin allyl ester.of a small one at the 6(7) position is sufficient to
To a stirred solution of palladium(II)acetate (25 mg, 0.11 mMol) inconvert -lactam substrates into potent inhibitors of
acetonitrile (2 ml) was added a solution of triphenylphosphine (140class C-lactamases. X-ray crystal structures demon-
mg, 0.53 mMol) in acetonitrile (1.3 ml). A thick yellow-green precipi-
strate that this bulky side chain forces the inhibitor to tate formed in 15 min. To the vigorously stirred precipitate was
adopt a catalytically incompetent conformation in the added tri(n-butyl)stannane (66l, 0.25 mMol). Stirring was continued
for 30 min, at which point a solution of ATMO-penicillin allyl esteracyl-enzyme complex, blocking further reaction. These
(1.83 g, 4.16 mMol) in ethyl acetate (15 ml) was added in one portion.molecules are thus able to proceed through the first
The reaction mixture immediately became homogeneous. A solutionhalf of the -lactamase mechanism but are unable to
of sodium 2-ethylhexanoate in ethyl acetate (0.5 M, 10ml) was addedcontinue through the second, hydrolytic half of the
dropwise over 5 min, during which time a precipitate formed. The
reaction, and so remain bound in the acyl-adduct, ef- crude precipitated ATMO-penicillin sodium salt was isolated by low-
fectively trapping the enzyme. We distinguish these speed centrifugation of the reaction mixture. The solid was washed
with ether (3
) and dried in vacuo to afford the crude salt (1.05 g).sterically hindered -lactams from mechanism-based
Pure ATMO-penicillin was isolated as the ammonium salt by pre-inhibitors, whose covalent adducts typically form
parative HPLC and lyophilization of relevant fractions. Method: 19through off-pathway reactions. Steric hindrance pro-
mm 
 300 mm Waters X-terra C18 column (5 m), 20 ml/min, gradi-vides a simple criterion for the design of new
ent elution 5%–40% methanol in aqueous ammonium carbonate
-lactamase inhibitors, and it may be that such a de- over 30 min. ES/MS (positive ion) 400.1 [M  H], 240.9 [-lactam
sign strategy could be applied to other enzymes that “vertical cleavage”] (negative ion) 398.1 [M H]; 1H NMR in Dimeth-
ylsulfoxide-d6 (shift, multiplicity/integration, J Hz) 1.39, s 3H; 1.49,proceed through a covalent adduct as part of their
s 3H; 3.74, s 3H; 5.39, d 1H; J  3.9; 5.43, d/d 1H, J  3.9/7.4; 6.68,catalytic mechanism. These inhibitors also show some
s 1H; 9.36, d 1H; J  7.4.promise as antibiotics against resistant bacteria, with
7-[Z-(2-Aminothiazol-4-Yl)-Methoximinoacetamido]-1-one of the new -lactams active against -lactamase-
Carba(Dethia)-3-Chloro-Cephem-4-Carboxylic Acid,
expressing strains of Enterobacter cloacae, Esche- Ammonium Salt (“ATMO-Carbacephem”)
richia coli, and Staphylococcus aureus that are resis- This was prepared in an analogous manner, with the analytical sam-
tant to most other -lactam antibiotics. ple isolated by preparative HPLC. ES/MS (positive ion) 385.2 [M 
H], 406.9 [MNa]; (negative ion) 383.1 [MH]; 1H NMR in Dimethyl-
sulfoxide-d6 (shift, multiplicity/integration, J Hz) 1.81, m 2H; 2.70, mExperimental Procedures
2H; 3.69, s 3H; 3.78, m 1H; 5.11, d/d 1H; J  5.0/7.3; 6.65, S 1H;
9.27, d 1H; J  7.3.Chemical Synthesis
Reactions were carried out with continuous stirring under a positive
pressure of nitrogen except where noted. Reagents and solvents
Enzymologywere purchased and used without further purification. Thin layer
Escherichia coli AmpC -lactamase was expressed and purified tochromatography was performed with 0.25 mm silica gel 60 plates
homogeneity as previously described [16]. AmpC-catalyzed -lac-with a 254 nm fluorescent indicator from E. Merck (Mumbai, India).
tam hydrolysis was monitored in an HP8453 UV/visible spectropho-Plates were developed in a covered chamber and visualized by
tometer. For cephalothin (Sigma, St. Louis, MO) and cefotaximeultraviolet light or by treatment with 5% phosphomolybdic acid in
(Sigma), reactions were monitored at 265 nm, penicillin G (Sigma)ethanol followed by heating. Flash chromatography was carried out
and ATMO-penicillin at 235 nm, loracarbef at 262 nm, and ATMO-with silica gel 60, 230–400 mesh (0.040–0.063 mm particle size)
carbacephem at 260 nm. The reaction buffer used during the assayspurchased from EM Science (Cincinnati, OH). High performance
was 50 mM Tris-HCl (Fisher, Fair Lawn, NJ) at pH 7 in doubly deion-liquid chromatography (HPLC) purifications were performed using
ized water. kcat and KM values were determined at an enzyme concen-Waters (Milford, MA) X-terra C18 columns with the specified solvent
tration of 1.75 nM, with enzyme concentration determined, fromsystem and flow rate. NMR spectra are reported as chemical shifts
more concentrated stocks, based on an 280 of 0.098 M1cm1.in parts per million (ppm) downfield from a tetramethylsilane internal
Where KM values could not be determined because they were sostandard (0 ppm). 1H NMR spectra were recorded in the solvent
low (i.e., for molecules that behaved more like inhibitors), IC50 valuesindicated on a Varian Mercury spectrometer at 400.21 MHz. Elec-
were determined against 200 M cephalothin for ATMO-penicillintrospray mass spectra (ES/MS) were recorded on a Micromass (Bev-
and cefotaxime and 200 M nitrocefin (Oxoid, Ogdensburg, NY)erly, MA) Platform LCZ spectrometer.
in the case of ATMO-carbacephem [14]. Except for compounds6-[Z-(2-Aminothiazol-4-Yl)-Methoximinoacetamido]-
synthesized specifically for this study (ATMO-penicillin, ATMO-car-Penicillanic Acid, Ammonium Salt (“ATMO-Penicillin”)
bacephem), all compounds were used as supplied from the manu-Z-(2-aminothiazol-4-yl)-methoximinoacetic acid (1.01 g, 5 mMol)
was slurried in N,N-dimethylformamide (15 ml) at room temperature. facturers without further purification.
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buffer at pH 8.7 as described [9]. AmpC crystals were harvested 4. Matagne, A., Dubus, A., Galleni, M., and Frere, J.M. (1999). The
beta-lactamase cycle: a tale of selective pressure and bacterialand placed in a 6 l drop of 1.7 M KPi (pH 8.7) and soaked with
excess ligand (50–70 mM) for 15 min and then transferred to a ingenuity. Nat. Prod. Rep. 16, 1–19.
5. Oefner, C., D’Arcy, A., Daly, J.J., Gubernator, K., Charnas, R.L.,fresh drop for another 15 min to obtain the acyl-enzyme complexes
presented here. The crystals were then transferred to a pH 8.7 Heinze, I., Hubschwerlen, C., and Winkler, F.K. (1990). Refined
crystal structure of beta-lactamase from Citrobacter freundiicryoprotectant solution containing 20% sucrose, 1.7 M KPi, and
excess ligand (50 mM) for 10–15 s before being flash frozen in liquid indicates a mechanism for beta-lactam hydrolysis. Nature 343,
284–288.nitrogen.
Diffraction data were collected at DND-CAT beamline 5-IDB at 6. Patera, A., Blaszczak, L.C., and Shoichet, B.K. (2000). Crystal
structures of substrate and inhibitor complexes with AmpCthe Advanced Photon Source at 100 K using a Mar-CCD detector.
Reflections were indexed, integrated, and scaled using HKL soft- beta-lactamase: possible implications for substrate-assisted
catalysis. J. Am. Chem. Soc. 122, 10504–10512.ware [27] (Table 2). The complexes crystallized in the C2 space
group, with two AmpC molecules per asymmetric unit, each con- 7. Caselli, E., Powers, R.A., Blaszczak, L.C., Wu, C.Y.E., Prati, F.,
and Shoichet, B.K. (2001). Energetic, structural, and antimicro-taining 358 amino acid residues. Out of a possible 716 residues,
715 were included in each final model. The initial model was built bial analyses of beta-lactam side chain recognition by beta-
lactamases. Chem. Biol. 8, 17–31.by molecular substitution using an apo AmpC structure (Protein
Data Bank ID code 1KE4) without solvent molecules. This model 8. Crichlow, G.V., Nukaga, M., Doppalapudi, V.R., Buynak, J.D.,
and Knox, J.R. (2001). Inhibition of class C beta-lactamases:was refined with CNS [28] using rigid body, simulated annealing,
positional minimization, and individual B factor refinement, with the structure of a reaction intermediate with a cephem sulfone.
Biochemistry 40, 6233–6239.maximum likelihood target, and included bulk solvent correction
and a 2 cutoff for the data. Manual model building into-A weighted 9. Trehan, I., Beadle, B.M., and Shoichet, B.K. (2001). Inhibition of
AmpC beta-lactamase through a destabilizing interaction in theelectron density maps using O [29] alternated with rounds of posi-
tional and B factor refinement in CNS. active site. Biochemistry 40, 7992–7999.
10. Powers, R.A., Caselli, E., Focia, P.J., Prati, F., and Shoichet,Molecule two in the asymmetric unit exhibited stronger electron
density for the ligands in both structures. Ligands were built into B.K. (2001). Structures of ceftazidime and its transition-state
analogue in complex with AmpC beta-lactamase: implicationsthe 2|FO|-|FC| and |FO|-|FC| difference density in this monomer for
both structures. Simulated-annealing omit density was used to con- for resistance mutations and inhibitor design. Biochemistry 40,
9207–9214.firm the placement of the ligands in the active site. The relative
occupancies of the two conformations for each ligand were deter- 11. Faraci, W.S., and Pratt, R.F. (1985). Mechanism of inhibition of
the PC1 beta-lactamase of Staphylococcus aureus by cephalo-mined based on optimization of the difference density for each and
also by comparing the refined thermal factors of the ligand atoms sporins: importance of the 3-leaving group. Biochemistry 24,
903–910.with those of Ser64, to which they are covalently bound.
12. Faraci, W.S., and Pratt, R.F. (1986). Interactions of cephalospo-
rins with the Streptomyces R61 DD- transpeptidase/carboxy-Microbiology
peptidase. Influence of the 3-substituent. Biochem. J. 238,The effectiveness of cephalothin, cefotaxime, loracarbef, and
309–312.ATMO-carbacephem was tested against bacteria growing in liquid
13. Faraci, W.S., and Pratt, R.F. (1986). Mechanism of inhibition ofculture. The compounds were dissolved in 50 mM Tris buffer, and
RTEM-2 beta-lactamase by cephamycins: relative importanceserial dilutions were performed into Luria Broth (Difco, Detroit, MI).
of the 7 alpha-methoxy group and the 3 leaving group. Bio-Each broth solution was then inoculated with bacterial cells from
chemistry 25, 2934–2941.an overnight culture that had been diluted to give an inoculum con-
14. Mazzella, L.J., and Pratt, R.F. (1989). Effect of the 3-leavingcentration of approximately 5 
 105 cfu/ml. The MIC of the test
group on turnover of cephem antibiotics by a class C beta-compounds was determined against both AmpC-expressing and
lactamase. Biochem. J. 259, 255–260.AmpC-negative laboratory strains of JM109 Escherichia coli and
15. Murphy, B.P., and Pratt, R.F. (1988). Evidence for an oxyanion-lactamase-expressing clinical isolates of Enterobacter cloacae
hole in serine beta-lactamases and DD- peptidases. Biochem.and Staphylococcus aureus. In E. coli, AmpC was expressed off of
J. 256, 669–672.the high-expression vector pOGO295, which is the same vector
16. Usher, K.C., Blaszczak, L.C., Weston, G.S., Shoichet, B.K., andused for protein expression and purification [16].
Remington, S.J. (1998). Three-dimensional structure of AmpC
beta-lactamase from Escherichia coli bound to a transition-Acknowledgments
state analogue: possible implications for the oxyanion hypothe-
sis and for inhibitor design. Biochemistry 37, 16082–16092.This work was supported by NIH GM63815 (to B.K.S.). I.T. is a
17. Wilkinson, A.S., Ward, S., Kania, M., Page, M.G., and Wharton,Howard Hughes Medical Institute Medical Student Research Train-
C.W. (1999). Multiple conformations of the acylenzyme formeding Fellow. We thank B. Beadle, G. Minasov, R. Powers, and X.Wang
in the hydrolysis of methicillin by Citrobacter freundii beta-lacta-for technical assistance and P. Focia, S. McGovern, and X. Wang
mase: a time-resolved FTIR spectroscopic study. Biochemistryfor comments on this manuscript. Loracarbef was a gift of Eli Lilly.
38, 3851–3856.The E. cloacae and S. aureus isolates were gifts from Jesu´s Bla´z-
18. Hokenson, M.J., Cope, G.A., Lewis, E.R., Oberg, K.A., and Fink,quez. The DuPont-Northwestern-Dow Collaborative Access Team
A.L. (2000). Enzyme-induced strain/distortion in the ground-(DND-CAT) Synchrotron Research Center at the Advanced Photon
state ES complex in beta-lactamase catalysis revealed by FTIR.Source is supported by grants from the NSF, the State of Illinois,
Biochemistry 39, 6538–6545.and the U.S. Department of Energy.
19. Beadle, B.M., Trehan, I., Focia, P.J., and Shoichet, B.K. (2002).
Structural milestones in the pathway of an amide hydrolase:Received: May 3, 2002
substrate, acyl, and product complexes of cephalothin withRevised: July 2, 2002
AmpC beta-lactamase. Structure 10, 413–424.Accepted: July 15, 2002
20. Lobkovsky, E., Billings, E.M., Moews, P.C., Rahil, J., Pratt, R.F.,
and Knox, J.R. (1994). Crystallographic structure of a phospho-References
nate derivative of the Enterobacter cloacae P99 cephalospo-
rinase: mechanistic interpretation of a beta-lactamase transi-1. Neu, H.C. (1992). The crisis in antibiotic resistance. Science
tion-state analog. Biochemistry 33, 6762–6772.257, 1064–1073.
21. Faraci, W.S., and Pratt, R.F. (1987). Nucleophilic re-activation2. Davies, J. (1994). Inactivation of antibiotics and the dissemina-
tion of resistance genes. Science 264, 375–382. of the PC1 beta-lactamase of Staphylococcus aureus and of
Chemistry & Biology
980
the DD-peptidase of Streptomyces R61 after their inactivation
by cephalosporins and cephamycins. Biochem. J. 246, 651–658.
22. Boyd, D.B. (1984). Electronic structures of cephalosporins and
penicillins. 15. Inductive effect of the 3-position side chain in
cephalosporins. J. Med. Chem. 27, 63–66.
23. Nishikawa, J., Watanabe, F., Shudou, M., Terui, Y., and Na-
risada, M. (1987). 1H NMR study of degradation mechanisms of
oxacephem derivatives with various 3-substituents in alkaline
solution. J. Med. Chem. 30, 523–527.
24. Chen, C.C.H., and Herzberg, O. (2001). Structures of the acyl-
enzyme complexes of the Staphylococcus aureus beta-lacta-
mase mutant Glu166Asp:Asn170Gln with benzylpenicillin and
cephaloridine. Biochemistry 40, 2351–2358.
25. Maveyraud, L., Mourey, L., Kotra, L.P., Pedelacq, J.D., Guillet,
V., Mobashery, S., and Samama, J.P. (1998). Structural basis
for clinical longevity of carbapenem antibiotics in the face of
challenge by the common class A beta-lactamases from the
antibiotic-resistant bacteria. J. Am. Chem. Soc. 120, 9748–9752.
26. Manhas, M.S., Gala, K., Bari, S.S., and Bose, A.K. (1983). A
covalent synthesis of esters of 6-aminopenicillanic acid. Synthe-
sis 549–552.
27. Otwinowski, Z., and Minor, W. (1997). Processing of X-ray dif-
fraction data collected in oscillation mode. Methods Enzymol.
276, 307–326.
28. Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros,
P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges,
M., Pannu, N.S., et al. (1998). Crystallography & NMR system: a
new software suite for macromolecular structure determination.
Acta Crystallogr. D Biol. Crystallogr. 54, 905–921.
29. Jones, T.A., Zou, J.Y., Cowan, S.W., and Kjeldgaard, M. (1991).
Improved methods for building protein models in electron den-
sity maps and the location of errors in these models. Acta Crys-
tallogr. A 47, 110–119.
Accession Numbers
Structure factors and coordinates for amoxicillin and ATMO-penicil-
lin in complex with AmpC have been deposited in the Protein Data
Bank with ID codes 1LL9 and 1LLB, respectively.
